Back to CLDX

Trails Edge Capital Partners, LP → CLDX

Trails Edge Capital Partners, LP CLDX Position History

Celldex Therapeutics, Inc.

Quarters held
1
Latest value
$24.8M
Q3 2026
Peak value
$24.8M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$24.8M765.0K——

Other funds holding CLDX

Other Trails Edge Capital Partners, LP positions

LBRX

LB PHARMACEUTICALS INC

$49.4M
LBRX

LB PHARMACEUTICALS INC

$44.1M
BMRN

BIOMARIN PHARMACEUTICAL INC

$40M
PCVX

VAXCYTE INC

$38.5M
NRIX

NURIX THERAPEUTICS INC

$38.2M
ACAD

ACADIA PHARMACEUTICALS INC

$37.9M
NRIX

NURIX THERAPEUTICS INC

$37.3M
OBX

OBSIDIAN THERAPEUTICS INC

$34.3M